Search results
Showing 3031 to 3045 of 8221 results
This agreement constitutes the entire agreement between the Organisation and NICE relating to the Confidential Information
Home Get involved Our committees...
Training and development opportunities at NICE
Find out more about the types of organisations that can register to be a stakeholder at NICE.
People can comment on our guidance at specific stages in its development.
Home Get involved Our committees...
Read the biographies for all members of the NICE antimicrobial evaluation committee.
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
Tell us what matters to you, your organisation or your community.
Details and meeting dates of the antimicrobials evaluation panel
Biographies and registered interests for members of the Technology Appraisal Committee C
Find out more about NICE technology appraisals advisory committee D members
This indicator covers mortality rates directly associated with VTE. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG80
This indicator covers the percentage of patients who reached 75 years old in the preceding 12 months, who have received a shingles vaccine between the ages of 70 and 75 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM201
Bipolar, schizophrenia and other psychoses: annual blood pressure (IND84)
This indicator covers the percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood pressure in the preceding 15 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator covers the percentage of patients with diabetes with a record of a foot examination and risk classification: 1) low risk (normal sensation, palpable pulses), 2) increased risk (neuropathy or absent pulses), 3) high risk (neuropathy or absent pulses plus deformity or skin changes or previous ulcer) or 4) ulcerated foot within the preceding 15 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM17